Bedell Frazier Investment Counseling, LLC Biogen Inc. Transaction History
Bedell Frazier Investment Counseling, LLC
- $418 Million
- Q3 2024
A detailed history of Bedell Frazier Investment Counseling, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Bedell Frazier Investment Counseling, LLC holds 31,318 shares of BIIB stock, worth $4.67 Million. This represents 1.45% of its overall portfolio holdings.
Number of Shares
31,318
Previous 13,690
128.77%
Holding current value
$4.67 Million
Previous $3.17 Million
91.3%
% of portfolio
1.45%
Previous 0.77%
Shares
10 transactions
Others Institutions Holding BIIB
# of Institutions
1,037Shares Held
126MCall Options Held
1.13MPut Options Held
1.43M-
Vanguard Group Inc Valley Forge, PA16.7MShares$2.49 Billion0.06% of portfolio
-
Primecap Management CO Pasadena, CA16.3MShares$2.43 Billion2.37% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.17 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.34MShares$1.09 Billion0.06% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$765 Million0.18% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.5B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...